The Tax Line Took the Quarter, the Reserve Line Took the Call

Results vs. Consensus

Shell reported on the morning of February 5 and the shares closed the session at $74.63, down 5.28%. That is the largest single-session decline of our coverage period and it happened on a day the S&P 500 fell 1.23% and the closest European integrated peer fell 2.63%. Roughly four percentage points of the move belong to the company.

Q4 2025 Scorecard

The per-ADS row needs a note, because Shell's own reporting and most data feeds are on different denominations and the gap manufactures fake surprises. Shell reports Adjusted Earnings per share of $0.57 per ordinary share. One ADS is two ordinary shares, so $1.14 per ADS. Coverage that compares the $0.57 against a per-ADS forecast produces a headline miss of roughly 50% that does not exist, and coverage that compares $1.14 against a per-ordinary-share forecast produces a beat that does not exist either. Both appeared in the syndicated write-ups on the day.

Year-over-Year Comparison

The last row is the one that reframes the print. On a like-for-like fourth quarter, the tax rate is essentially unchanged. The adjusted effective rate is calculated as the adjusted taxation charge divided by the sum of adjusted earnings including non-controlling interest and that same charge: $2,909M on $6,216M for Q4 2025, and $3,371M on $7,137M for Q4 2024. Shell's fourth quarter carries an annual non-cash reassessment of deferred taxes, and it carried one last year too.

Sequential Comparison

Net debt excluding leases is our subtraction, not a Shell disclosure. Total debt includes lease liabilities of $28,933M at December 31 and $28,571M at September 30, and net debt is reported inclusive of them. On the CFO's framing, gearing is 20.7% including leases and roughly 9% excluding them.

Full Year 2025

Two rows deserve to be read together. Adjusted earnings fell 21.9% and adjusted earnings per share fell 16.2%, and the 5.7-point gap is the buyback, which cut the weighted average share count 6.5% across the year. That is the per-share compounding pillar doing precisely what we underwrote it to do, in the worst macro year of the coverage period. The other pairing, basic earnings per share up 18.8% against adjusted earnings per share down 16.2%, is identified items: a net loss of $7.4B in 2024 against a net loss of only $0.1B in 2025.

Revenue and Volumes

There is nothing wrong with the volume set. Total oil and gas production of 2,859 kboe/d is the highest of the three quarters the results table sets side by side, up 1.6% year over year and 1.3% sequentially. LNG liquefaction of 7.81Mt rose 7% sequentially on lower maintenance and the LNG Canada ramp. Refinery processing intake was broadly flat at 1,178 kb/d. Marketing sales volumes fell 4.4% sequentially, which is seasonality that Shell guided to four weeks earlier.

The full-year LNG numbers are the more interesting pair. Liquefaction volumes fell 2.3% to 28.42Mt, on the Trinidad and Tobago ownership restructuring and higher maintenance, partly offset by LNG Canada. Sales volumes rose 10.8% to 72.94Mt against a Capital Markets Day ambition of 4–5% annual growth through 2030. Shell sold 2.6 times what it liquefied. That ratio is the trading and third-party-supply business, and it is the reason the Integrated Gas segment cannot be modelled as a liquefaction plant with a margin.

Assessment: revenue is a distraction here and the volume set is a small positive. The operational base delivered; what happened below it is the story.

Margins and Cost

Underlying operating expenses of $9,436M rose 4.9% sequentially and 3.3% year over year. We said last quarter that the Q3 increase was LNG Canada and Monaca carrying full operating cost before full output, that it should reverse, and that Q1 and Q2 2026 were the test. It did not reverse in Q4, and the test moves out a quarter. The full-year number is better: $35,032M against $35,707M, down 1.9%, with $2,016M of structural cost reduction delivered inside a $675M net decline, meaning $1,341M of inflation, activity and new-operation cost ran the other way.

ROACE is 9.4% for the full year against 11.3% for 2024, on the Adjusted Earnings plus non-controlling interest basis that is the only ROACE the results announcement discloses. That is 190bp lower. On the call the CEO described the 9.4% as "up compared to 2024," which is not that basis, and the results table is what we grade against. On the disclosed basis, return on capital fell in a year when the oil price fell about $10 a barrel, and the level remains below the double-digit ambition.

Assessment: the cost programme is working and the operating expense line is not yet showing it quarter to quarter, because inflation and new-asset cost are absorbing most of the saving. That is a slower version of the pillar, not a broken one. The ROACE framing on the call was more generous than the table supports.

Earnings per Share and the Share Count

Weighted average ordinary shares fell to 5,739.6M from 6,148.4M, down 6.6% year over year, and the year-end count is 5,718,636,398 after 396,394,760 shares were retired during 2025. Cash spent on repurchases was $13,879M, within $19M of the 2024 figure. The CFO's framing on the call is that Shell has bought back roughly 25% of its shares over three years at an average price roughly 20% below the level at which the shares were trading on the day.

The arithmetic consequence matters more than the rhetoric. Adjusted earnings fell 21.9% for the year; adjusted earnings per share fell 16.2%. In the fourth quarter, adjusted earnings fell 11.1% year over year and adjusted earnings per share fell 5.0%. The buyback is converting a bad macro year into a less bad per-share year at a rate of roughly 6% annually, and it is doing so with the cash flow statement under visible strain.

Assessment: the per-share machine still works. The question this quarter raised is not whether it works but for how long it can be funded from free cash flow rather than the balance sheet, and Q4 answered that question badly.

Segment Performance

The segment rows include non-controlling interest and the group Adjusted Earnings figure excludes it, which is why the rows sum $51M above the headline in the quarter and $285M above it for the year. The full-year segment rows sum to $18,813M against the $18,814M subtotal, a $1M rounding difference inside the filing.

Integrated Gas

Adjusted earnings of $1,661M fell 22.5% sequentially and 23.3% year over year, on a quarter in which production rose 2% to 948 kboe/d and liquefaction rose 7% to 7.81Mt. The bridge Shell gives is unfavourable tax movements of $260M, lower realised prices of $163M and higher operating expenses of $147M, partly offset by higher volumes of $101M. Tax alone is 54% of the $482M sequential decline in a segment whose volumes went up.

The full year is the harder read. Adjusted earnings of $8,024M are down 29.6% on 2024, and the single largest item in Shell's own bridge is "the combined effect of lower contributions from trading and optimisation and lower realised prices," a $3,034M decrease that fuses the two and sizes neither separately. This is exactly the disclosure structure we flagged at initiation, and a full year of it is more consequential than a quarter.

Assessment: the operational story in Integrated Gas is good and getting better as LNG Canada ramps. The earnings story is unreadable, because the two variables that matter most are reported as one number. A segment producing $8.0B of annual adjusted earnings that will not separate price from trading is the single largest reason our multiple is where it is.

Upstream

Adjusted earnings of $1,570M fell 13.0% sequentially and 6.7% year over year. Production rose 3% sequentially to 1,892 kboe/d on new oil and lighter maintenance. The sequential bridge is lower realised liquids prices of $486M and higher operating expenses of $115M, offset by a $271M comparative benefit from the Brazil participation-interest rebalancing that hit Q3.

Reported income for the segment was $3,648M, more than double the adjusted figure, because identified items included $2,282M of disposal gains, mainly the incorporation of the Adura joint venture with Equinor in the UK North Sea on December 1. Adura is now the largest independent producer in the UK North Sea, it sits outside the consolidated production numbers, and Shell's economics from it arrive as dividends on the joint venture's own timetable. The Q1 2026 Upstream production guide of 1,700–1,900 kboe/d, against 1,892 delivered in Q4, is mostly that deconsolidation.

Assessment: Upstream did its job in a falling price deck, and the Adura structure converts a consolidated production line into an uncontrolled dividend stream. Management declined to size the dividend, which is defensible for a jointly controlled venture and still leaves a hole in the 2026 cash bridge.

Marketing

This is the quarter's worst segment and the least discussed. Adjusted earnings of $578M fell 56.1% sequentially and 31.1% year over year. Shell's bridge is a $490M decrease in Marketing margins on seasonally lower Mobility and Lubricants volumes and weaker Sectors and Decarbonisation margins, plus $285M of unfavourable tax movements including the non-cash reassessment of deferred tax in a joint venture. Reported income was a $99M loss after $527M of impairment charges.

Cash was worse than earnings. Marketing produced a $75M operating cash outflow in the quarter, against a $1,788M inflow in Q3, driven by $1,230M of timing outflows on emissions certificates and biofuel programmes. Shell flagged this on January 8, telling the market to expect roughly $1.5 billion of emissions-certificate timing outflow at group level. The outcome was a group net outflow of $0.8 billion on emissions certificates and biofuel programmes, inside which sat $1.4 billion of German Fuel Emissions Trading Act payments.

The full year tells the opposite story: adjusted earnings of $3,994M are up 2.8% on 2024 and the CFO said Mobility and Lubricants each delivered their best-ever result, with Mobility ROACE rising to over 15% from 12% and Lubricants to over 21% from 19%. Roughly 800 lower-performing branded sites were closed or divested during the year.

Assessment: the quarter is seasonality, a non-cash tax item and a pre-announced cash-timing swing, layered on a franchise that had its best year. Do not extrapolate the quarter. Do note that Marketing is now the segment where the deferred-tax reassessment does the most damage to a headline, and that Shell has said so in advance twice.

Chemicals and Products

The segment swung to an adjusted loss of $66M from $550M of profit in Q3. Inside it, Products earned $523M and Chemicals lost $589M. For the full year, Products earned $2,177M and Chemicals lost $1,125M. Refinery utilisation of 95% was a point below Q3 and the full-year figure of 92% was seven points better than 2024 on lower planned maintenance. Chemicals utilisation fell to 76% from 80% on higher planned and unplanned maintenance, including a planned downturn at Monaca.

The sequential bridge is a $263M decrease in Chemicals margins and a $155M decrease in Products margins, "mainly driven by lower trading and optimisation and partly offset by higher refining margins," plus $125M of higher operating expenses and $117M of unfavourable tax. Shell had told the Street on January 8 that Chemicals adjusted earnings would be "a significant loss" and that the segment would be "below break-even," and that trading and optimisation would be "significantly lower than Q3'25."

The November completion of the Canadian oil sands swap removed Shell's remaining mining interest and associated synthetic crude reserves in exchange for an additional 10% of the Scotford upgrader and the Quest carbon capture facility. Shell no longer has any oil sands activities. That transaction is also the largest single line in the reserve reduction discussed below.

Assessment: Products is a real business earning real money and Chemicals is a $1.1B annual loss with no dated path to profitability. What changed this quarter is that unit-by-unit shutdowns moved onto the record as an option. That is the first concrete escalation in three quarters of asking.

Renewables and Energy Solutions

Adjusted earnings of $131M were the best quarter of the year and the full-year figure of $172M is a $669M swing from a $497M loss in 2024. The quarter's improvement is a $67M favourable fair valuation of an investment. Shell says plainly that most activities in the segment were loss-making and were more than offset by trading, optimisation and energy marketing, which is the same sentence it has written for several quarters.

Cash flow was a $405M outflow on $704M of working capital outflow. Renewable generation capacity in operation rose to 4.2GW from 3.4GW a year earlier, while capacity under construction or committed for sale fell 53% to 1.9GW on the Atlantic Shores withdrawal, transfers into operation and ownership dilution. Operating expenses of $2,549M for the year are down 12.6% from $2,915M.

Assessment: the segment is being shrunk into a trading and flexible-generation business and the arithmetic is improving. The honest caveat is unchanged: a segment that is profitable only because trading offsets its operating losses is not a business with a margin, it is a trading book with assets attached.

Corporate

A $567M net expense, $184M worse than Q3 and $187M worse than Q4 2024, on $278M of unfavourable tax movements partly offset by $114M of favourable net interest. The full-year expense of $1,870M is $98M better than 2024. Guidance for Q1 2026 is a net expense of $400–600M, a step down from the Q4 outcome.

Operating Metrics and Guidance Delivery

Shell publishes a quarterly update note about four weeks before each print carrying its own quantified ranges. The Q4 2025 note is dated January 8, 2026. It is a better test of the business than consensus, because it is the company grading itself against numbers it chose, in public, in advance. Twenty of those ranges can be graded directly against the results announcement.

Eighteen of twenty inside, two outside on the favourable side. The depreciation and taxation rows are graded on the adjusted basis the update note uses, which cross-walks exactly to the results announcement's own reconciliation table: the note's Q3 2025 adjusted figures for each segment match the filed Q3 numbers to the rounding.

Four further ranges cannot be graded, and the reason is a disclosure gap rather than a miss. The note guides underlying operating expenses per segment, and the results announcement discloses operating expenses per segment but reconciles to underlying operating expenses only at group level. The four segment opex ranges are therefore not checkable from the published results, which is a small but real asymmetry in a company that otherwise grades itself well.

Set against the ranges published with the Q3 results in October, the record is better still. Those bands were wider, and the January note narrowed six of them. Refinery utilisation is the clearest case: the October band was 87–95% and the January band 93–97%, and the 95% outcome sits at the top of the first and in the middle of the second.

Assessment: this is the second consecutive quarter in which Shell landed inside essentially everything it told the market it would. At initiation we said guidance credibility needed three more quarters before it could carry a multiple. It has now had one of them. It is not yet a pillar we pay for, but the same January 8 note pre-announced the deferred-tax charge that caused this quarter's shortfall, and that is the main reason a 7.8% consensus miss does not move our rating.

Key Topics & Management Commentary

Overall Management Tone: confident on execution and visibly uncomfortable on resource. The prepared remarks were a delivery scorecard read as a list of things done ahead of schedule, and the tone through Q&A stayed level. Where management was least convincing was on the two questions it could not answer with a completed action: what fills the resource gap after 2030, and when Chemicals stops consuming cash. Both drew strategic-patience answers rather than dated plans, and both were asked more than once.

1. The cost programme landed three years early

This was the number we said last quarter was the disclosure gap to press, and it was the first substantive thing said on the call. Structural cost reductions since 2022 reached $5,135M, inside the $5–7B target band that runs to the end of 2028, with $2,016M of it delivered in 2025 alone. The mechanics are disclosed for the first time as well.

"By the end of 2025, we had already achieved $5.1 billion of reductions with more to come. Nearly 60% of the structural cost reductions came from operational efficiencies, a leaner corporate center and faster value-based decision-making. Achieving this target 3 years early demonstrates the drive of our organization to deliver." — Wael Sawan, CEO

Pressed on why the target was not simply raised, the CEO reframed the commitment upward without changing the number.

"My expectation of the team is we do hit the higher end of that come 2028. So we will be driving towards it." — Wael Sawan, CEO

The reconciliation in the results announcement is worth reading alongside the headline. Underlying operating expenses fell $675M in 2025, of which structural cost reduction contributed $2,016M and everything else, inflation, activity levels and the cost of new operations, added $1,341M back. The programme is bigger than the visible saving by a factor of three.

Assessment: pillar confirmed and upgraded in specificity. A cost programme that hits its floor three years early with the CEO publicly steering to the ceiling is worth another $1–2B of annualised saving by 2028, and it needs no help from the oil price. The caveat is that the reconciliation shows how much of it the market never sees.

2. The reserve replacement ratio, and the answer management chose to give

The preliminary reserves update in the results announcement is short and consequential. Total proved reserves on an SEC basis are expected to be approximately 8.1 billion boe. The proved reserves replacement ratio is expected to be -40% for the year and 55% on a three-year average. Excluding acquisitions and divestments those become 73% and 84%. Acquisitions and divestments account for a net decrease of roughly 1.2 billion boe, largely the Canadian oil sands swap at 0.7 billion boe and the Nigeria onshore SPDC divestment at 0.4 billion boe.

The CFO put the reserve-life consequence on the record and defended the decisions that produced it.

"So let me go specifically on R/P. So roughly speaking, we were at about 7.8 years, as you know, now, which came down from 9. How did we -- what were the decision-making between coming down from 9? Two main elements of that. One was the SPDC sales, so the sale in Nigeria of assets and the other, of course, was the move with respect to oil sands, both of which we've talked over the last year or so with you. And of course, both were very conscious decisions." — Sinead Gorman, CFO

The defence is that the $2B of deepwater bolt-ons Shell bought in 2025 produce high-margin barrels with shorter reserve lives, and that this was a value choice rather than an accident.

"We chose to go with high margin, therefore, creating value rather than just trying to manage to a metric." — Sinead Gorman, CFO

The CEO's framing was that the gap to 2030 is closed and the gap beyond 2035 is not, and that Shell has bought itself time to be selective.

"I mentioned in Capital Markets Day that we had a gap to 2030 that was close to 100,000 barrels per day to be able to, for example, keep our liquids flat. I'm pleased to say that with the $2 billion of deepwater bolt-ons that we did in 2025 and improved recovery from some of the reservoirs we have, we already have largely plugged that gap of the 100,000 barrels per day. ... Your question, though, is a fair one when you look out to 2035. We still have a resource gap there that we plan to fill." — Wael Sawan, CEO

Assessment: the answer is intellectually consistent and strategically incomplete. It is true that reserve life is an input to value rather than value itself, and true that a 20-year barrel at a poor margin is worth less than a 7-year barrel at a good one. It is also true that a -40% replacement ratio, 73% before portfolio effects, describes a company that is not replacing what it produces on either measure. Management has converted the question into a 2035 problem and asked for patience. That is a real answer, and it is also the first time in our coverage that Shell has conceded a portfolio gap it previously denied.

3. The buyback: held flat, and a closer call than the number suggests

Shell announced a $3.5B programme to complete before the Q1 2026 results, the seventeenth consecutive quarter at or above $3B, and raised the dividend 3.9% to $0.372 per ordinary share. It also disclosed that distributions ran at 52% of operating cash flow on a rolling four-quarter basis, against a 40–50% target band.

"We've always said to you that sort of 40% to 50% in terms of CFFO distribution is sacrosanct. And of course, that varies a little bit quarter-to-quarter because it is through the cycle. So you see that in our thinking. And of course, this quarter was 52%, but you have volatility with price and everything else coming through. So we're very comfortable and very focused on staying within that." — Sinead Gorman, CFO

On the cash-flow statement, the four quarters of 2025 give the same figure: $8,471M of dividends plus $13,879M of repurchases is $22,350M against $42,863M of operating cash flow, or 52.1%. The quarter alone ran higher, at 58.2% ($5,493M against $9,438M), so the band was exceeded on both bases.

Assessment: the level cleared our stated downgrade trigger and the ratio did not clear Shell's own policy. Both facts are true and the first matters more at this price, because the policy is a through-cycle ratio and a single year above it in a down-cycle is what a through-cycle ratio is for. What we will not accept is the same answer twice. A second consecutive year above 50% with gearing still rising converts "sacrosanct" into a description of intent rather than a constraint.

4. Cash conversion, and the number that is not in the headline

Operating cash flow of $9,438M looks like a modest decline until it is decomposed. Working capital contributed a $1,275M inflow this quarter, against a $28M outflow in Q3. Strip it out and operating cash flow excluding working capital is $8,164M against $12,235M, down 33.3%, and against $10,755M a year earlier, down 24.1%. This is Shell's own disclosure, Reference H in the results announcement, and it is the quality check that separates an earnings quarter from a timing quarter.

Free cash flow of $4,249M against $5,493M distributed is 0.77 times cover. Net debt rose $4,483M to $45,687M, which the announcement attributes to free cash flow of $4.2B being more than offset by $3.4B of buybacks, $2.1B of dividends, $1.8B of lease additions and $1.2B of interest payments. Gearing rose 190bp to 20.7%.

The CFO's defence is the ten-year range and the price at which the shares were retired.

"Our balance sheet is sitting at some 20% in terms of gearing. Now remember, we've had a range of 10% to 30%. You always say to me, let's look back over time. So over the 10 years, we've gone between 10% and 30%. So sitting at some 20% is very healthy. I'm very comfortable with that." — Sinead Gorman, CFO

Her second point is that three-year net debt is roughly flat and the gearing increase is about two points, three-quarters of which she attributes to distributions and the remainder to the Netherlands pension reform's effect on equity.

Assessment: this is the quarter's genuine deterioration and it is not disguised. Shell disclosed the ex-working-capital number, disclosed the 52%, and disclosed the net debt bridge. The question for 2026 is arithmetic rather than disclosure: at $14B of annual buyback plus roughly $8.4B of dividends against free cash flow that was $26.1B in 2025 and falling, the policy funds itself only if the earnings base stops declining.

5. Trading and optimisation, sized for the first time at the low end

At initiation we made the unsized trading contribution a standing bear point and said the specific thing that would retire it was a quarterly number. This quarter produced something less than that and more than nothing: an annual band placement.

"They have done more towards the lower end of that range in terms of -- you said 2% to 4% in terms of ROACE. But really pleased with what they deliver, and they're continuing to deliver this quarter as well." — Sinead Gorman, CFO

Against average capital employed of $219,441M, the low end of a 2–4% ROACE uplift is on the order of $4–5B of annual pre-interest contribution. Management would not go further, and the fourth quarter was explicitly described as seasonally softer for the crude and products desks.

The counterpoint is the full-year Integrated Gas bridge, which fuses "lower contributions from trading and optimisation and lower realised prices" into a single $3,034M decrease. A company that can place trading in a band for the group cannot separate it from price in its largest segment.

Assessment: incremental progress on a point that has run three quarters. Knowing that 2025 was at the low end of the band is materially more useful than knowing nothing, because it tells you the earnings base does not depend on an exceptional trading year. It also removes the easiest bull argument, that the disappointing year was a trading year that will revert.

6. Chemicals: unit shutdowns arrive on the record

Chemicals lost $589M in the quarter and $1,125M for the year. Asked what Shell controls, the CEO separated the strategic answer from the operational one and was candid that the first has not moved.

"Nothing's changed from what we talked about in Capital Markets Day. What I also said in Capital Markets Day is we are going to be patient because while we know where we want to go with it, we do not want to be selling at bottom-of-cycle conditions. ... I won't update you at this stage on where things are because there's nothing specific to update on." — Wael Sawan, CEO

"Where I would say I have less patience is in our own self-help. ... we have identified a few hundred million dollars' worth of cost reductions, CapEx reductions to be able to just ensure that we get closer and closer towards free cash flow neutrality." — Wael Sawan, CEO

Pressed later on why capacity is not simply being shut, he added the option that had not previously been stated.

"Shame on me, I should have also mentioned that, of course, we are also looking at unit by unit shutdowns where required. At the end of the day, we're looking at cash cost of each of these units and making the choices depending on where we are in the cycle. But nothing is off the table." — Wael Sawan, CEO

The CFO framed 2026 as the year this is fixed: "Fixing and repositioning this business is a key priority in 2026."

Assessment: three quarters of asking has produced a cost plan, a target of free cash flow neutrality rather than profit, and now the possibility of closing units. It has not produced a portfolio action, a date, or a quantified end state. The escalation is real and the pace is slow. A segment losing $1.1B a year inside a company distributing $22.4B a year is affordable and is not strategically neutral.

7. Capital reallocation becomes the stated next phase

The most forward-looking thing said on the call was a change of emphasis rather than an announcement. Having spent three years embedding performance, management said the next phase is moving capital.

"What I can say and what I will be saying to our investors is both Sinead and I will bring that same focus and rigor now as we have really gotten the self-sustaining performance loop into the company. We will now look at portfolio reallocation, how we are going to be reallocating capital to the opportunities that allow us to unlock even further growth post 2030, and that's where our attention will continue to go in the coming years." — Wael Sawan, CEO

He then sized the opportunity.

"we believe there is over 15% of the capital employed that we have, the $225 billion, that we could actually redeploy into higher return opportunities, which we want to actively be looking at." — Wael Sawan, CEO

Closing capital employed in the results announcement is $220,747M, so the CEO's rounding is close and the implied redeployable pool is over $33B. At initiation his framing was $45B, $25B in Chemicals and $20B in Renewables. The new number is smaller and the new framing is about redeployment rather than repair.

Assessment: this is the most important sentence on the call for a multi-year holder and the least tradeable. Shell has just told the market that the cost phase is finished and the capital phase is starting, and that a third of a trillion dollars of balance sheet is in scope for roughly a tenth of it to move. Whether that becomes value or a deal cycle is the thing to watch through 2026.

8. The M&A market and the new opportunity set

Asked where the bid-ask sits, the CEO gave a rare quantified read on the market rather than on Shell.

"It used to be at the higher end of the 60% to 70% range, and now we're closer to the lower end of that 60% to 70% range. And it's sort of in that space. So it is not out of what we have seen, call it, mid-cycle conditions in the past." — Wael Sawan, CEO

On geography, the list is new: Kuwait, where the CEO had been days earlier following a KPC opening; Libya, where Shell has an MOU on fields; Venezuela, where Shell says it is well positioned on gas; and Iraq. He also volunteered a rare admission of a past error, saying of the portfolio, "I wish we hadn't walked away from Guyana when we did. That's the honest truth."

The discipline framing was repeated several times, most compactly as a description of the capital budget's own history: $25–27B originally, cut to $22–25B at the 2023 Capital Markets Day, cut again to $20–22B in 2025, and not fully spent.

Assessment: the appetite is up and the bar is stated as unchanged. Those two can coexist for a while and not indefinitely. For a company whose equity case rests on returning cash rather than deploying it, a visible pivot toward acquisition is the single largest risk to the thesis that is entirely within management's control.

9. Free cash flow per share: sub-5% against a greater-than-10% target

At the 2025 Capital Markets Day Shell committed to annual growth in normalised free cash flow per share of over 10% through 2030. Challenged directly that 2025 delivered under 5%, the CFO neither disputed the figure nor conceded disappointment.

"So in terms of where we disappointed in terms of where it was for 2025? No. We knew where it was expected to come. And we've, of course, got a wave of different projects that are coming through. We've still got LNG Canada, of course, that is still to ramp up to its full capacity ... It is not linear." — Sinead Gorman, CFO

Assessment: "not linear" is doing a lot of work in a five-year target whose first year came in at less than half the rate. The defence is credible on project timing and it means the remaining four years must average above the headline rate. This is the cleanest falsifiable commitment Shell has made and nobody has yet written down what the 2026 number needs to be.

10. Artificial intelligence, and the refusal to bank it

Asked what the SLB agentic-AI deployment actually does, the CEO described the groundwork, the applications in subsurface interpretation and predictive maintenance, and then declined to take credit for savings that have not arrived.

"We are not yet banking all sorts of cost reductions coming out of agentic AI because, to be honest, we're still learning. There is a lot of hype around it at the moment, and we're trying to focus on where can we actually deliver real cash gains rather than talk about it. And so I will withhold judgment as to how much it will impact the bottom line until I can give you an honest reflection on the impact it can have." — Wael Sawan, CEO

Assessment: in a reporting season where technology claims are free, refusing to put a number on one is a credibility deposit. It is also consistent with how this management team has handled the cost programme, which it under-promised and delivered three years early.

11. Kazakhstan, and a rare statement of reduced appetite

On the compensation claims from the government of Kazakhstan, the CEO declined detail because of live proceedings but did not decline the strategic consequence.

"I think suffice it to say that we are disappointed that we can't see alignment between the joint venture partners and the government on some of these topics. It is -- it does impact our appetite to invest further in Kazakhstan. So we watch the situation with care." — Wael Sawan, CEO

Assessment: unquantified, and the only country on the call where Shell said its appetite has fallen. No amount at stake was given and no provision was disclosed. It belongs on the watch list rather than in a model.

Guidance & Outlook

The capital expenditure guide is the single most important line in the table and it is the one that did not fire our downgrade trigger. We published last quarter that a 2026 guide materially above $22B would move us to Hold, because it would convert the distribution from a funded policy into the adjustment variable. Shell guided $20–22B, the same range it delivered in 2025 at $20,915M, and the CEO went out of his way to say the budget has been cut twice and is not fully spent.

Implied quarter-over-quarter ramp: the Q1 2026 volume guides are close to flat on Q4 actuals with one exception. Upstream steps down just over 90 kboe/d at the midpoint, and that is the Adura joint venture leaving the consolidated production line rather than a decline. Chemicals utilisation is guided to 79–87% from 76% delivered, on the Monaca downturn ending, which should be worth something against a $589M quarterly loss. Corporate expense improves by roughly $70M at the midpoint.

Street at: consensus entering the print sat at $3.51–3.53B of quarterly adjusted earnings and $18.79B for the year, against $3,256M and $18,529M delivered. The Street was 1.4% high on the year and 7.8% high on the quarter, which tells you the miss was concentrated in the seasonal tax line that Shell had already flagged and the Street had modelled through.

Guidance style: conservative and narrowing. Shell now publishes two sets of ranges per quarter, the wide set with the prior quarter's results and a narrowed set four weeks before the print, and has landed inside essentially all of them for two consecutive quarters. The January 8 note also pre-announced the tax reassessment, the Chemicals loss, the roughly $1.5B emissions-certificate timing outflow and the roughly $1.2B German mineral oil tax payment. Almost nothing in this print was unflagged.

Analyst Q&A Highlights

Reserve life, and whether the business is simply shrinking

Reserves opened the call and dominated it, returning across five separate exchanges, one of which opened by observing that the topic had already been exhausted. The framing was that three years of cost reduction have coincided with a falling reserve life, and that the company's message has shifted from denying a portfolio problem to acknowledging one without urgency. Management answered on intrinsic value per share, on the closed gap to 2030, and on the open gap to 2035.

Q: "I feel obliged to kick us off on reserves. You've listed a huge amount of portfolio refocus in the Upstream. But I guess, to Shell, we've had 3 years of sprint and cost takeout, but at the same time, reserve life has fallen 15%. And if I take you back a couple of years ago, you used to say there was no portfolio problem. And I think now the message is morphed into one that sort of acknowledges there is a bit of a problem to address, but there's no hurry. So I guess the question is what is the plan? How do we frame the time line around hurry? And how can you counter the market concerns that the business is simply shrinking?"
— Alastair Syme, Citi

A: "What we have tried to do is look at the resource as an important KPI in the overall mix, but most importantly, look at the cash flow that's coming from it. ... Your question, though, is a fair one when you look out to 2035. We still have a resource gap there that we plan to fill. But we want to make sure that the bar continues to be high there. And we have a few years to be able to fill that gap. So this is not ignoring the issue. But this is derisking what we can see in front of us, what we can control."
— Wael Sawan, CEO

Assessment: management conceded the 2035 gap explicitly, which is new, and declined to put a timeline or a capital number against it, which is not. "A few years to be able to fill that gap" is the entire commitment. The exchange establishes reserve replacement as a live thesis question rather than a data point, and the market treated it that way for the rest of the session.

How close the buyback decision was

The second question went directly at the capital-allocation judgement rather than the number, asking whether a re-rated share price entered the decision to hold the programme flat. The answer disclosed that the quarter ran above the stated payout band and defended the repurchase on the price at which shares have historically been retired.

Q: "Just a question on the buybacks. I'm curious as when you set the buyback, how much of a close call that was this quarter? Because I understand you've got a strong balance sheet, prices seem to be holding up better than expected, but also for the first time in a while, we've got more people buying energy stocks and your shares are clearly rerated with that and they're more expensive. So was that considered at all in your decision to leave it flat? And how much -- how close was that call?"
— Joshua Stone, UBS

A: "one of the first things I would say is what we've looked at is the fact that we've bought back roughly, what, 25% of our shares, I think, over the last 3 years. And of course, that's at some 20% below where our share price is today. ... And of course, this quarter was 52%, but you have volatility with price and everything else coming through. So we're very comfortable and very focused on staying within that."
— Sinead Gorman, CFO

Assessment: the question asked how close the call was and the answer never said. What it did say is more useful: the payout ran at 52% against a 40–50% band, and management is comfortable. That is the first time in our coverage that the ratio has been conceded as exceeded, and it was volunteered rather than extracted.

Chemicals restructuring, and group return on capital

A recurring line of questioning connected the sub-double-digit group return on capital to the widening Chemicals loss and asked what had progressed on the restructuring intention announced at the 2025 Capital Markets Day. The answer separated a strategic process on hold from an operational programme in motion.

Q: "looking at group return on capital, obviously, it is below double digit. It's clearly not helped by widening Chemicals losses. The Chemicals down cycle appears to be a really prolonged one, which is clearly something that cannot be controlled. So I wanted to talk around what you are controlling in Chemicals and in particular, to ask about progress on the announcement you made at CMD25 of the restructuring intention for Chemicals? So how far has that progressed?"
— Irene Himona, Bernstein

A: "Nothing's changed from what we talked about in Capital Markets Day. What I also said in Capital Markets Day is we are going to be patient because while we know where we want to go with it, we do not want to be selling at bottom-of-cycle conditions. ... I won't update you at this stage on where things are because there's nothing specific to update on."
— Wael Sawan, CEO

Assessment: "nothing specific to update on" is the third consecutive quarter without a portfolio answer on Chemicals. The same answer also contained the ROACE claim that the results table does not support, which is the one place on the call where management's characterisation and its own disclosure diverge.

Whether to shut chemicals capacity outright

A later exchange pushed harder, arguing that a downcycle of another four to five years makes a few hundred million of cost reduction insufficient and that somebody has to close plants. This drew the only genuinely new disclosure on Chemicals in the quarter.

Q: "Last quarter, you talked about cutting several hundred millions of dollars from Chemicals. I think you referenced that again today. But I mean, this could be a very extended down cycle of up to another 4 to 5 years. So a few hundred million of cost reductions may not be enough. And presumably somebody has to shut capacity. So what exactly would be stopping you from outright shutting capacity? Is it the benefit of integration with your refining plants? Is it the environmental cleanup costs or labor issues in Europe?"
— Kim Fustier, HSBC

A: "Shame on me, I should have also mentioned that, of course, we are also looking at unit by unit shutdowns where required. At the end of the day, we're looking at cash cost of each of these units and making the choices depending on where we are in the cycle. But nothing is off the table."
— Wael Sawan, CEO

Assessment: the admission that shutdowns were not mentioned until asked is the tell. Unit closures were already under consideration and were not in the prepared remarks, on a segment that lost $1,125M in the year. This is the single most actionable thing said about Chemicals in three quarters, and it surfaced only under pressure.

Sizing the trading contribution for the full year

The question that has gone unanswered since initiation finally landed in a form management would engage with: not what trading earned, but where within its own published 2–4% ROACE uplift band the year fell.

Q: "I wanted to ask about trading. ... In 2025, broadly speaking, were we at the upper end of that range, lower end of the range? What was roughly the contribution of trading?"
— Martijn Rats, Morgan Stanley

A: "They have done more towards the lower end of that range in terms of -- you said 2% to 4% in terms of ROACE. But really pleased with what they deliver, and they're continuing to deliver this quarter as well."
— Sinead Gorman, CFO

Assessment: the first placement Shell has given. It cuts both ways and mostly favours the bull: a year this weak was not a weak trading year being disguised, and it was not a strong trading year flattering the base. The segment disclosure still fuses trading with realised prices, so the group band placement is the ceiling of what can currently be modelled.

The free cash flow per share target against a sub-5% first year

A pointed sequence connected the cost programme's early completion to the target it was meant to serve, observing that the first year of a greater-than-10% per-share compounding ambition delivered less than half that.

Q: "the free cash flow growth per share target or ambition of more than 10% out to 2025 -- out to 2030. 2025 was sub-5%. So was that a disappointing number to you? Or was it just as you expected? And basically, it does imply that there needs to be an acceleration of free cash flow growth. So when do you actually see that? Is that '26? Or is it more '28 to '30?"
— Lydia Rainforth, Barclays

A: "So in terms of where we disappointed in terms of where it was for 2025? No. We knew where it was expected to come. And we've, of course, got a wave of different projects that are coming through. We've still got LNG Canada, of course, that is still to ramp up to its full capacity, and we talked about it as well, the number of different projects that seem to go. It is not linear."
— Sinead Gorman, CFO

Assessment: the answer accepts the number and rejects the inference. Neither the 2026 expectation nor the shape of the remaining path was given, and nobody followed up. A five-year compounding target whose first year runs at under half rate, with four years to average above the headline, is the most quantifiable open question in the equity and the least discussed.

Whether the portfolio was historically underinvested

The bluntest question of the call asked the CEO to judge the company he inherited, and pushed the CFO on whether the per-share target survives without a flat real oil price or added leverage.

Q: "As you inherited the portfolio several years ago now, do you believe legacy Shell has underinvested? And if so, how do you fix it in short order, whether through M&A or without a step-up in CapEx? ... Going back to your strategy day, you had assumed a flat real oil price. Can you maintain that 10% free cash flow growth per share without the help of a flat real oil price or without leverage?"
— Douglas Leggate, Wolfe Research

A: "Look, I mean, I don't often look back. And if I were to look back, I would say, I wish we hadn't walked away from Guyana when we did. That's the honest truth. How do we resolve the issue going forward? Look, at the end of the day, I think we play to our strengths. I mean, today, we can underwrite a production flat line on liquids, and we have said we're growing our gas by 2% between now and 2030."
— Wael Sawan, CEO

Assessment: a genuine and unusual admission on the first half, and no answer at all on the second. The question of whether the per-share target holds without a flat real oil price or added leverage was reframed into a description of balance-sheet comfort and never addressed on its own terms. Given that gearing rose 300bp over the year while the target's first year ran at under half rate, that is the omission with the most money attached to it.

What They're NOT Saying

1. The 2026 free cash flow per share number: the greater-than-10% annual target through 2030 delivered under 5% in its first year, and management declined to say what 2026 needs to be or when the acceleration arrives. "It is not linear" is the entire forward statement on a five-year commitment whose arithmetic now requires the remaining four years to average above the headline rate.
2. Whether the per-share target survives a lower oil price: asked directly whether the target holds without a flat real oil price or without leverage, the answer moved to the ten-year gearing range and the average buyback price. The question was not answered and was not repeated.
3. The Adura dividend: a joint venture that took the UK North Sea business off the consolidated production line as of December 1 will return cash as dividends "with timing determined by the JV," and management said only that it expects "considerable dividends." No size, no cadence, no 2026 contribution. That is a hole in the cash bridge of a quarter that already missed on cash.
4. The segment underlying operating expense ranges: Shell guides underlying operating expenses per segment four weeks before the print and then discloses only reported operating expenses per segment, reconciling to underlying at group level. Four of its own published ranges cannot be graded by anyone outside the company. This is the one place its otherwise good self-grading breaks.
5. A quarterly trading number: the group-level band placement is progress and the segment note still fuses "lower contributions from trading and optimisation and lower realised prices" into one $3,034M line for the full year in Integrated Gas. Shell can place trading in a 2–4% band for the group and cannot separate it from price in its largest segment.
6. The Chemicals end state: three quarters of questions have produced a cost target, a free-cash-flow-neutrality ambition and, this quarter, the possibility of unit shutdowns. There is still no date, no capacity number, no disposal process and no answer to whether Chemicals is core. The restructuring intention announced at the March 2025 Capital Markets Day has "nothing specific to update on" eleven months later.
7. The ROACE comparison: the results announcement reports 9.4% for 2025 against 11.3% for 2024 on the only basis it discloses, a 190bp decline. On the call the figure was described as up compared with 2024. No alternative basis was named, and no reconciliation between the two characterisations was offered.
8. Kazakhstan: compensation claims exist, they are in legal proceedings, they have reduced Shell's appetite to invest further, and no amount, provision or identified item has been disclosed. The same disclosure posture as the Venture Global arbitration loss flagged last quarter, which also remains unquantified and went unmentioned this quarter.
9. What a second year above the payout band would mean: distributions ran at 52.1% of operating cash flow in 2025 against a 40–50% through-cycle band. Management said it is focused on staying within the range and did not say what happens if 2026 cash flow falls again. The buyback is the only variable large enough to close the gap.
10. The 2026 Chemicals utilisation implication: chemicals plant utilisation is guided up to 79–87% for Q1 from 76% delivered, on the Monaca downturn ending. Nobody asked what that is worth against a $589M quarterly loss, and management did not volunteer it.

Market Reaction

• Pre-print setup: SHEL closed at $78.79 on February 4, up 7.2% year to date against 0.5% for the S&P 500, up 8.1% over the trailing thirty days and up 18.4% over the trailing twelve months. That close was the top of a 52-week range of $59.75 to $78.79. The shares entered the print at their highest close of the year.
• Reaction session: results were published before the US open. The shares gapped down to open at $76.29, traded a $74.47 to $76.60 range and closed at $74.63, down 5.28% or $4.16.
• Volume: 11.4 million shares against a 30-day average of 5.3 million, 2.1 times normal.
• Peer and market context: the S&P 500 fell 1.23% on the session. Among peers, BP fell 2.63%, TotalEnergies 2.15%, Chevron 1.10% and ExxonMobil 1.02%. A Brent tracker fell 1.49% and a WTI tracker 1.53%. SHEL underperformed the index by 4.05 points and the closest European integrated peer by 2.65 points.

Strip out the roughly one and a half points that belong to a weak tape and a softer crude complex and something close to four points of the move is Shell's own. That is a large idiosyncratic reaction to a 7.8% miss on a quarter whose central negative, the annual deferred-tax reassessment, the company had disclosed in writing four weeks earlier and had produced at almost exactly the same rate in the comparable quarter a year before.

Three things explain the gap between the size of the miss and the size of the move. The first is positioning: the shares entered the print at a 52-week closing high after an 8.1% thirty-day run, so there was no cushion and every incremental buyer was already in. The second is the cash statement. Free cash flow covering distributions 0.77 times, net debt up $4.5B and gearing up 190bp is the combination that turns a soft quarter into a question about the buyback, and the buyback is the entire per-share case. The third is reserves. The preliminary update is a short paragraph in a long document, but a -40% replacement ratio and a reserve life falling from nine years to about 7.8 is the kind of disclosure that opens a call, dominates it, and gets repriced rather than reported.

What the reaction did not price is the offsetting half of the same print. The cost target was hit three years early. The buyback held at $3.5B for a seventeenth consecutive quarter while a European peer cut its own programme by 70% the day before. Capital expenditure for 2026 was guided to the range delivered in 2025. And eighteen of twenty published ranges landed inside, with the other two beating. A quarter can be this operationally clean and this poorly received at the same time, and that is usually where a holding becomes more attractive rather than less.

Street Perspective

Debate: Is a 7.8% miss on a pre-flagged tax line a real downgrade to the earnings power?

Bull view: the bull case being made is that the entire shortfall sits below the operating line in a fourth-quarter deferred-tax reassessment that recurs annually, ran at 47.2% in the comparable quarter a year ago, and was described in Shell's own pre-print note. The operating set beat: production up, liquefaction up seven percent, eighteen of twenty guided ranges inside. On this reading the run-rate earnings power is unchanged and the market repriced a calendar event.

Bear view: the bear camp contends that the tax argument is a distraction because the cash tells a different story. Operating cash flow excluding working capital fell a third sequentially and a quarter year over year, and the headline cash number was flattered by a working capital inflow rather than hurt by an outflow. Full-year free cash flow fell 34.1% while distributions stayed flat, and the gap was funded with $6.9B of additional net debt. Adjusted earnings per ADS of $1.14 is the lowest in seventeen quarters despite a share count down 6.6%.

Our take: the bull has the better argument on the quarter and the bear has the better argument on the year. Adjusting the tax rate to Q3's level would have turned a miss into a beat, so the quarter is genuinely a timing artefact. But the annual picture is not: $44,666M of operating cash flow excluding working capital against $52,625M, on $22,350M of distributions, is a business distributing more than half its cash flow into a declining cash base. The right conclusion is to leave the multiple alone and cut the earnings path, which is what we have done.

Debate: Does a -40% reserve replacement ratio matter for a company optimising value per share?

Bull view: the argument for ignoring it is that reserve life is an accounting metric and cash flow is the objective. The 1.2 billion boe of the reduction that came from acquisitions and divestments was deliberate: an oil sands position swapped for upgrader and carbon-capture interests, and a Nigerian onshore business Shell spent years exiting. The $2B redeployed into deepwater bought shorter-lived, higher-margin barrels, and management says the 2030 liquids gap is now closed. A company that buys a 7-year barrel at twice the margin of a 20-year barrel has improved, not deteriorated.

Bear view: the counter is that even stripping out portfolio effects, the replacement ratio is 73% for the year and 84% on a three-year average. Both are below one. Whatever the quality of the barrels, Shell is consuming its resource base faster than it is adding to it, and has been for three years. The answer to the 2035 gap is that there are a few years to fill it, which is a plan to have a plan. And the remedy on offer, acquisitions in Venezuela, Libya, Iraq and Kuwait, is the highest-risk capital deployment available to an integrated major.

Our take: the bear is right that the ex-portfolio numbers are the ones that matter and that they are below replacement. The bull is right that this is not an emergency: management has line of sight to 2030, and the equity case we underwrite does not require reserve growth, because it is a cost programme and a shrinking share count. Where this becomes a thesis risk is not the reserve number itself but its remedy. A management team that concedes a post-2035 gap, states that its appetite for M&A has risen, and says over 15% of a $221B capital base is available for redeployment has told you where the next large capital decision is coming from. We are adding this as a standing thesis point rather than treating it as a quarterly data item.

Debate: Is the buyback still funded, or is it now the adjustment variable?

Bull view: the bull view is that seventeen consecutive quarters at or above $3B, through a year in which Brent averaged over $10 a barrel lower, is the definition of a funded policy. Gearing at 20.7% sits in the middle of a ten-year 10–30% range, ex-lease net debt is $16.8B against $175.3B of equity, and a European peer that cut its programme by 70% the day before makes the contrast concrete. Full-year free cash flow of $26.1B still covered $22.4B of distributions 1.17 times.

Bear view: the bear view is that the quarter, not the year, is the leading indicator: 0.77 times cover, $4.5B of additional net debt in three months, and a quarterly payout at 58.2% of operating cash flow against a band that tops out at 50%. Management called the band sacrosanct and then exceeded it, for the quarter and for the year. If 2026 cash flow falls again, the only line large enough to close the gap is the $14B annual buyback, which is also the entire per-share case.

Our take: the bear describes the mechanism correctly and overstates the timing. A through-cycle payout ratio exceeded in a down-cycle year is the ratio working as designed, and Shell has $175B of equity and a gearing level mid-range by its own ten-year history. But the bear's point is the right thing to grade, and we are grading it explicitly: our downgrade trigger for 2026 is a quarterly programme below $3.0B, unchanged, and we are adding a second condition. A full year 2026 that again distributes above 50% of operating cash flow while gearing rises further would move us to Hold on its own, because at that point the policy is being funded by the balance sheet rather than by the business.

Model Update & Valuation Framework

Last quarter's estimates need honest grading before new ones are useful.

The Q4 miss is ours as much as the Street's, and the reason is instructive. We modelled the downstream utilisation bands and the Corporate expense guide, which were the things the Q3 call emphasised, and we did not model the annual deferred-tax reassessment, which is not in any guidance range and shows up only as a rate. That is a repeatable error and the fix is mechanical: Shell's fourth quarter carries an adjusted effective tax rate in the high forties, and any Q4 estimate should be built on that rather than on the running rate.

Valuation

At the February 5 close of $74.63, with 5,718,636,398 ordinary shares in issue at December 31 and an ADS equal to two ordinary shares, there are 2,859,318,199 ADS and the market capitalisation is roughly $213.4B. Against full-year adjusted earnings of $18,529M that is 11.5 times trailing earnings, essentially the same multiple the shares carried at our initiation, struck now on a lower and more clearly cyclical base.

Our twelve-month target reaches into early 2027, so the anchor rolls forward a year. The base case is 2027 adjusted earnings of $21.5B on an average 2,620M ADS, which is $8.21 per ADS. At 10.5 times that gives $86, unchanged, and 15.2% above the current price. Adding the 3.99% dividend yield gives a total return of roughly 19%.

The multiple moves from 11.0 times to 10.5 times and the anchor moves out a year, and those two changes very nearly cancel. That is deliberate rather than convenient. The half-turn comes off on the terms we set at initiation. We said then that we would not mark the multiple down for the trading contribution, the chemicals business or the 2026 oversupply risk while free cash flow covered the distribution 1.74 times, and this quarter it covered it 0.77 times. One of the three arguments for paying up has also weakened: the cost programme's remaining upside is smaller, since $5,135M of a $5–7B band is booked. Guidance credibility, another of the three, is stronger than it was, and it is what stops the half-turn becoming a full one. Rolling the anchor is the ordinary consequence of a target set in February 2026.

The bear case uses a reduced $3.0B quarterly programme, which retires fewer shares and therefore carries a higher average count. Implied prices are rounded to the dollar.

Shareholder yield at the current price. The newly raised dividend of $0.372 per ordinary share annualises to $2.976 per ADS, a 3.99% yield. The announced $3.5B quarterly programme annualises to $14.0B, or 6.56% of the $213.4B market capitalisation. The combined 10.55% is the number that carries the investment case, and it is higher than the 10.3% at initiation only because the share price is lower and the dividend was raised. What has changed underneath it is the cover: at initiation, quarterly free cash flow covered the distribution 1.74 times, and this quarter it covered it 0.77 times. The yield is the same size and less comfortably funded, which is precisely why the bear-case row exists.

Thesis Scorecard Post-Earnings

The pillars below are the ones established at initiation on the third-quarter print and carried in our standing thesis. They are graded here against what this quarter's results and call actually showed.

Overall: thesis intact and narrower. The two macro-independent drivers both strengthened: the cost programme hit its floor three years early with the CEO steering to the ceiling, and the share count fell 6.6% while earnings fell 21.9%, cutting the per-share decline to 16.2%. Guidance credibility added the first of the three further clean quarters we said it needed. Against that, the funding clause under the buyback weakened materially, return on capital fell 190bp on the disclosed basis, and a new and legitimate bear point arrived on the resource base. Conviction moves from 6 to 6, unchanged: the bull side got better and the bear side got a fourth member.

Action: hold and add on weakness, with two things to grade. The first is the Q1 2026 buyback against the unchanged $3.0B trigger. The second is new: whether the 2026 payout ratio comes back inside 50% of operating cash flow, because a second consecutive year above the band with gearing still rising would move us to Hold regardless of the buyback's headline size.

Bottom Line

Shell missed a $3.53B consensus with $3,256M, and the entire miss is a fourth-quarter deferred-tax reassessment that recurs every year, ran at almost exactly the same rate in the comparable quarter, and was described in writing four weeks before the print. At Q3's tax rate the same pre-tax income would have produced roughly $4.2B and the headline would have read as a 19% beat. The shares fell 5.28% on a session where the index fell 1.23% and the nearest peer fell 2.63%.

The reaction was not really about the tax line, and it should not have been. Three things happened in this print that are worth more than a quarterly number. The $5–7B cost target landed three years early at $5,135M, which is the disclosure we said last quarter was the gap to press. Eighteen of twenty published ranges landed inside, a second consecutive clean quarter that takes guidance credibility halfway to the threshold we set at initiation. And the reserve replacement ratio came in at -40% for the year, 73% excluding portfolio moves, with reserve life down from nine years to about 7.8, which management answered with value-per-share arithmetic and a promise that there are a few years to fill the post-2035 gap.

The honest problem is cash, not earnings. Operating cash flow excluding working capital fell 33.3% sequentially to $8,164M, the headline cash number was flattered by a $1,275M working capital inflow rather than hurt by an outflow, free cash flow covered the quarter's distribution 0.77 times, and full-year distributions ran at 52.1% of operating cash flow against a band management called sacrosanct. Net debt rose $6,878M across the year and gearing rose 300bp. None of that is hidden; Shell disclosed every line of it, including the ratio breach, without being asked.

Neither of the two downgrade triggers we published at initiation fired. The buyback held at $3.5B for a seventeenth consecutive quarter, in the same week a European peer cut its own programme by 70%, and 2026 capital expenditure was guided to the $20–22B range that 2025 delivered. At $74.63 the shares carry a 3.99% dividend and a 6.56% buyback run-rate for a 10.55% combined shareholder yield, on 11.5 times trailing adjusted earnings struck in the trough of the chemicals cycle and the bottom of the trading band.

What has changed is the margin of safety underneath that yield, and the arrival of a fourth bear point that is about the next five years rather than the next quarter. We are cutting the 2026 earnings path, rolling the valuation anchor to 2027, taking half a turn off the multiple, and adding a second downgrade condition on the payout ratio. The target is unchanged because those adjustments offset, not because nothing happened.

We are maintaining Outperform on Shell with a twelve-month target of $86.